Harris, D.D.; Sabe, S.A.; Broadwin, M.; Stone, C.; Xu, C.; Hu, J.; Kanuparthy, M.; Abid, M.R.; Sellke, F.W.
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia. Biomedicines 2024, 12, 588.
https://doi.org/10.3390/biomedicines12030588
AMA Style
Harris DD, Sabe SA, Broadwin M, Stone C, Xu C, Hu J, Kanuparthy M, Abid MR, Sellke FW.
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia. Biomedicines. 2024; 12(3):588.
https://doi.org/10.3390/biomedicines12030588
Chicago/Turabian Style
Harris, Dwight D., Sharif A. Sabe, Mark Broadwin, Christopher Stone, Cynthia Xu, Jiayu Hu, Meghamsh Kanuparthy, M. Ruhul Abid, and Frank W. Sellke.
2024. "Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia" Biomedicines 12, no. 3: 588.
https://doi.org/10.3390/biomedicines12030588
APA Style
Harris, D. D., Sabe, S. A., Broadwin, M., Stone, C., Xu, C., Hu, J., Kanuparthy, M., Abid, M. R., & Sellke, F. W.
(2024). Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia. Biomedicines, 12(3), 588.
https://doi.org/10.3390/biomedicines12030588